Home » EMA Outlines Plan to Ensure Quality of Foreign Clinical Trials
EMA Outlines Plan to Ensure Quality of Foreign Clinical Trials
May 10, 2012
The European Medicines Agency must increase inspections of foreign trials and work with regulators and ethics bodies in other countries to ensure there is a robust framework for the oversight and conduct of clinical trials, a new EMA report concludes.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor